Data / Form D filings / Rosetta Genomics Ltd.
Rosetta Genomics Ltd.: Form D filings
Rosetta Genomics Ltd., a biotechnology company in Rehovot, Israel, filed 6 Form D notices with the SEC between 2011 and 2012. The latest, on February 9, 2012, reports $1.8 million sold of a $1.8 million offering to 1 investor.
Find out what Rosetta Genomics Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10 PLAUT STREET, SCIENCE PARK, Rehovot, Israel, 76706
- Phone
- 972-73-222-0700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1362959
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 9, 2012 | New notice | $1,750,000 | $1,750,000 | $0 | 1 | Jan 26, 2012 | sec.gov |
| Nov 1, 2011 | New notice | $1,948,501 | $1,518,751 | $429,750 | 21 | Oct 19, 2011 | sec.gov |
| Mar 7, 2011 | Amendment | $2,725,000 | $2,725,000 | $0 | 13 | Feb 23, 2011 | sec.gov |
| Mar 7, 2011 | Amendment | $2,500,000 | $2,500,000 | $0 | 17 | Dec 1, 2010 | sec.gov |
| Mar 3, 2011 | New notice | $2,725,000 | $2,725,000 | $0 | 13 | Feb 23, 2011 | sec.gov |
| Mar 3, 2011 | New notice | $2,500,000 | $2,500,000 | $0 | 17 | Dec 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Markison | Director | |
| Ranit Aharonov | Executive Officer | |
| Joshua Rosensweig | Director | |
| Tomer Assis | Executive Officer | |
| Tali Yaron-Eldar | Director | |
| Kenneth Berlin | Executive Officer | |
| Gerald Dogon | Director | |
| David Sidransky | Director | |
| Oded Biran | Executive Officer |
Every Form D from the week of Feb 6, 2012 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rosetta Genomics Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.